ankylosing spondylitis chronic inflammatory rheumatic disease reduces quality life leads disability approximately patients spectrum therapeutic modalities limited renaissance use chloride treatment gives rise concern result reconsideration 224ra dosimetry discussion risks associated treatment present study introduces new dosimetric calculations alpha rays performed according model proposed international commission radiological protection icrp treatment schedule NUMBER intravenous injections NUMBER mbq 224ra absorbed doses calculated highest bone surface patient NUMBER gy resulting effective dose NUMBER sv 224ra radium beta gamma